Anaerobiosis induced by isoproterenol and glucagon in the presence of restricted coronary inflow.
D000693:Anaerobiosis; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation; D003327:Coronary Disease / Q000378:metabolism*; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D005934:Glucagon / Q000009:adverse effects / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D007263:Infusions, Parenteral; D007545:Isoproterenol / Q000009:adverse effects / Q000494:pharmacology*; D007773:Lactates / Q000378:metabolism; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects*; D011773:Pyruvates / Q000378:metabolism; D013268:Stimulation, Chemical; D014159:Transducers; D014693:Ventricular Fibrillation / Q000139:chemically induced
D007773:Lactates; D011773:Pyruvates; D005934:Glucagon; D007545:Isoproterenol